A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
31 August 2024 (18:00 - 18:50)
Organised by: 
About the speaker
University of Antwerp, Antwerp (Belgium)
9 More presentations in this session
Doctor D. Lindholm (Norrtalje, SE)
Access the full session
The Event
ESC Congress 2024
31 August 2024
18:00 CET
You may be interested in
Congress Presentation
Congress Session
